Gene Amplification Technologies Market to Hit Around USD 9.41 Bn by 2034
The gene amplification technology market size was exhibited at USD 8.95 billion in 2024 and is projected to hit around USD 9.41 billion by 2034, growing at a CAGR of -0.5% during the forecast period 2024 to 2034.
The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report@?https://www.novaoneadvisor.com/report/sample/8934
Gene Amplification Technologies Market Key Takeaways:
The increasing demand for research and development in molecular diagnostics, genomics, biological research, and genetic testing is a major driver of market expansion. The continued creation of multiple diagnostic tests utilizing different gene amplification techniques for COVID-19 has additionally boosted the market.
The market is significantly driven by the rapidly growing field of advanced DNA replication technologies. Due to advancements in technology in loop-mediated amplification, alternatives such as Nucleic Acid Sequence Based Amplification (NASBA), Rolling Circle Amplification (RCA), and Loop-Mediated Isothermal Amplification (LAMP) have been thoroughly researched.
These methods are gaining more popularity as they require no expensive thermal cyclers, have fast amplification rates, and can easily multiply from a single cell. These factors are anticipated to boost the utilization of products available in this market and in turn enhance the natural revenue generation.
By Product Insights
The kits and reagents segment accounted for the largest revenue share of 68.1% in 2024. The segment growth is anticipated to be boosted during the forecast period by the increasing demand for kits and reagents in molecular diagnostics and genomics research, along with a multitude of companies providing a variety of kits, media, and reagents. Due to the extensive use of PCR-based amplification, numerous companies provide PCR instruments. Due to the rising use of gene amplification technologies, companies in the market are concentrating on launching innovative new products in this sector.
Software & services is expected to register the fastest CAGR of 2.2% during the forecast period.
By Technology Insights
The Polymerase Chain Reaction (PCR)-bases amplification segment accounted for the largest share of 72.0% in 2024. The widespread utilization of PCR technology in various end-use applications is responsible for this. In addition, various technological challenges associated to PCR technology have encouraged the advancement and adoption of alternative technologies such as Loop-Mediated Isothermal Amplification (LAMP) and Multiple Displacement Amplification. Eiken Chemical Co., Ltd. and HiberGene Diagnostics are among the companies that have developed new tests for identifying the SARS-CoV-2 virus, utilizing LAMP technology.
Nucleic Acid Sequence Based Amplification is projected to grow at the fastest CAGR of 1.4% over the forecast period.
Gene Amplification Technologies Market By Application Insights
The Diagnostics and Pharmaceutical segment captures the largest revenue share of 72.7% in 2024. This is due to diagnostic tests for genetic diseases and disorders often utilize gene amplification techniques. These technologies are also used in the early identification and management of patients by assisting in early recognition of cancer and other conditions. Moreover, the increasing need for personalized care and specific medications is also contributing to the revenue increase in this sector.
The forensic and paternity testing segment is expected to register the fastest CAGR of 2.1% during the forecast period.
Gene Amplification Technologies Market By Sample Type Insights
The cell lines segment held the largest revenue share of 39.8% in 2024. This can be attributed to the wide availability of products for amplification using cell line samples. These kits are available at low prices and are easy to use, thereby increasing their usage in the market. The development of more robust and reliable cell lines has expanded their applications in gene amplification research and diagnostics. These advancements have led to increased efficiency and reproducibility in experiments, driving the growth of the cell lines segment.
Agricultural & food sample is projected to grow at the fastest CAGR over the forecast period.
Gene Amplification Technologies Market By End Use Insights
The Academic and Research Institutes segment captured the largest revenue share of 27.0% in 2024. Academic and research institutions lead in essential research, advancing gene amplification technologies and their uses. These organizations are essential for progressing scientific knowledge and comprehension, aiding in the general growth of the discipline. Educational institutions have the duty of teaching and preparing future scientists and researchers in gene amplification technologies. Investing in education is leading to the development of a talented workforce, which is fueling advancement and expansion in the market.
The forensic labs segment is projected to grow at the second largest revenue share of 24.9% in 2024
Gene Amplification Technologies Market By Regional Insights
North America dominated the gene amplification technologies market in 2024. The increasing need for gene amplification technologies in this area can be attributed to its hosting of some of the largest biotechnology and pharmaceutical companies globally. Also, another contributing factor to the growth of market revenue in this region is the support of government programs that aid in biotechnology Research & Development (R&D). Additionally, the region is anticipated to experience growth in market revenue due to substantial investments in genomics research and the demand for personalized treatment options.
U.S. Gene Amplification Technologies Market Trends
The Gene Amplification Technologies market in the U.S. dominated the market share with a share of 84.2% in 2024 due to the increasing popularity of molecular diagnostics for cancer presence of major market players and highly developed healthcare infrastructure in this region. The U.S. government's growing financial support for medical research and infrastructure is expected to drive the growth of the gene amplification technologies market in the country, leading to significant advancements in genomics within the healthcare sector.
Europe Gene Amplification Technologies Market Trends
Europe Gene Amplification Technologies market in the Europe dominated the market share with share of 26.3% in 2024 due to the abundance of leading manufacturers of gene amplification technologies. Furthermore, the market revenue growth of this region is anticipated to be boosted by government programs backing biotechnology R&D and increasing demand for personalized treatment in the upcoming forecast period.
UK Gene Amplification Technologies market is expected to grow rapidly in the coming years due to rapid evolution of DNA sequencing technologies in the recent years. The research and development or in other words the scientific study conducted in the UK has been remarkable and impressive due to presence of many universities and research centers of world class. The UK government offer a massive support for research and development across different fields such as the life sciences and biotechnology. The NHS is one of the most extensive and oldest healthcare systems globally, and for that reason, the healthcare requirement for diagnostic tools and technology is high.
Asia Pacific Gene Amplification Technologies Market Trends
Asia Pacific is anticipated to experience rapid growth during the forecast period due to supportive government efforts to enhance healthcare infrastructure. Growing research in genomics and molecular diagnostics, along with the abundant skilled workforce, have contributed to market expansion in developing countries such as China and India. In addition, the growth of market revenue in this region is anticipated to be driven by higher investments in R&D and healthcare infrastructure, as well as the increasing availability of skilled labor and affordable manufacturing options in countries such as China and India.
China Gene Amplification Technologies marketheld a substantial market share in 2024. There is an anticipated increase in the demand for whole genome amplification in China during the expected timeframe. The rise of the industry is due to the higher occurrence of different illnesses and the increasing demand for genetic research in the nation. The government in China is expected to increase the need for whole genome amplification through the implementation of beneficial healthcare projects.
Some of the prominent players in the gene amplification technology market include:
Gene Amplification Technologies Market Recent Developments
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2034. For this study, Nova one advisor, Inc. has segmented the gene amplification technology market
Technology
Application
Sample Type
Product
End Use
Regional
Immediate Delivery Available | Buy This Premium Research https://www.novaoneadvisor.com/report/checkout/8934
Access our Premium Real Time Data Intelligence Tool, Visit: www.precedencestatistics.com
You can place an order or ask any questions, please feel free to [email protected]| +1 9197 992 333
About US
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.
Connect with Us
Address: Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
IND Address: 707, Nandan Probiz, Baner,?Pune (MH) – 411045, India
USA:?+1 804 441 9344
APAC:?+61 485 981 310 or +91 87933 22019
Europe:?+44 7383 092 044
Email: [email protected]
You can place an order or ask any questions, please feel free to contact at?[email protected] ?| +1 804 441 9344